<DOC>
	<DOCNO>NCT02288351</DOCNO>
	<brief_summary>The purpose study investigate small intestinal remodel reprogramming glucose metabolism patient Type 2 Diabetes Mellitus ( T2DM ) undergo laparoscopic Roux-en-Y Gastric Bypass ( RYGB ) . Our specific goal determine gene protein expression level GLUT-1 regulate Roux limb whether major mechanism remission T2DM follow RYGB . The two aim study : 1 ) demonstrate basement membrane glucose transporter 1 ( GLUT-1 ) upregulated Roux limb follow RYGB , 2 ) demonstrate upregulation GLUT-1 major mechanism improvement glycemic control observe T2DM patient undergo RYGB .</brief_summary>
	<brief_title>Intestinal Remodeling And Reprogramming Glucose Metabolism Following Laparoscopic Roux-en-Y Gastric Bypass</brief_title>
	<detailed_description />
	<criteria>1 . Diagnosis Type 2 Diabetes Mellitus 2 . Age 18 65 year age 3 . BMI &gt; 35kg/mÂ² 4 . Diagnosis gastritis , esophagitis , ulcer , mucosal abnormality discover routine preoperative upper endoscopy , require followup endoscopy postoperative period . 1 . Patients undergoing revision another bariatric procedure RYGB 2 . Presence seizure disorder ( GLUT1 deficiency syndrome ) 3 . Use Tricyclic antidepressants 4 . Use tobacco product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Roux-en-Y gastric bypass</keyword>
</DOC>